Colony Group LLC Neurocrine Biosciences Inc Transaction History

Colony Group LLC

$6.66 Billion
Q3 2023

A detailed history of Colony Group LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Colony Group LLC holds 40,649 shares of NBIX stock, worth $5.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

40,649

Previous 41,443 1.92%

Holding current value

$5.1 Million

Previous $3.91 Million 17.02%

% of portfolio

0.07%

Previous 0.06%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $74,651 - $92,977	-794 Reduced 1.92%	40,649 $4.57 Million
Q2 2023 Aug 15, 2023	BUY	$89.53 - $104.87 $1,701 - $1,992	19 Added 0.05%	41,443 $3.91 Million
Q1 2023 May 16, 2023	BUY	$94.11 - $123.02 $3.11 Million - $4.07 Million	33,069 Added 395.8%	41,424 $4.19 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $154,210 - $183,601	1,445 Added 20.91%	8,355 $998,000
Q3 2022 Nov 15, 2022	SELL	$92.03 - $107.81 $184 - $215	-2 Reduced 0.03%	6,910 $734,000
Q2 2022 Aug 16, 2022	BUY	$75.79 - $100.07 $151 - $200	2 Added 0.03%	6,912 $674,000
Q1 2022 May 16, 2022	SELL	$72.45 - $94.81 $14,127 - $18,487	-195 Reduced 2.74%	6,910 $648,000
Q4 2021 Feb 15, 2022	SELL	$79.65 - $106.22 $35,603 - $47,480	-447 Reduced 5.92%	7,105 $605,000
Q1 2021 May 21, 2021	BUY	$87.57 - $119.4 $33,013 - $45,013	377 Added 5.25%	7,552 $734,000
Q4 2020 Feb 16, 2021	SELL	$86.91 - $108.33 $116,720 - $145,487	-1,343 Reduced 15.77%	7,175 $688,000
Q3 2020 Nov 17, 2020	SELL	$96.16 - $135.15 $59,330 - $83,387	-617 Reduced 6.75%	8,518 $819,000
Q2 2020 Aug 13, 2020	SELL	$85.09 - $130.36 $4,935 - $7,560	-58 Reduced 0.63%	9,135 $1.11 Million
Q1 2020 May 18, 2020	SELL	$75.11 - $113.76 $61,064 - $92,486	-813 Reduced 8.13%	9,193 $796,000
Q4 2019 Feb 18, 2020	SELL	$86.8 - $118.57 $502,485 - $686,401	-5,789 Reduced 36.65%	10,006 $1.08 Million
Q3 2019 Nov 26, 2019	SELL	$83.82 - $101.5 $92,453 - $111,954	-1,103 Reduced 6.53%	15,795 $1.42 Million
Q2 2019 Aug 19, 2019	BUY	$72.24 - $91.27 $1.22 Million - $1.54 Million	16,898 New	16,898 $1.43 Million

Others Institutions Holding NBIX

# of Institutions

629

Shares Held

94.2M

Call Options Held

692K

Put Options Held

406K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Colony Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Colony Group LLC with notifications on news.

Account